About

Lupin Limited, an Indian multinational pharmaceutical company, was founded in 1968 and is headquartered in Mumbai, Maharashtra, India. Operating as a public company, Lupin primarily focuses on manufacturing generic drugs, with a comprehensive product portfolio that addresses therapeutic areas including paediatrics, cardiovascular, anti-infectives, diabetology, asthma, and anti-tuberculosis. The company reported a significant revenue of 22,192 crore (US$2.6 billion) in 2025.